The efficiency and safety of alendronate versus teriparatide for treatment glucocorticoid-induced osteoporosis: A meta-analysis and systematic review of randomized controlled trials

BACKGROUND: Glucocorticoid-induced osteoporosis (GIOP) is the most common secondary osteoporosis, alendronate (ALE) and teriparatide (TPTD) are widely used in the treatment of GIOP. However, which of these two drugs has a better curative effect needs the support of evidence-based medicine. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhi-Ming, Zhang, Min, Zong, Yuan, Zhang, Ding, Shen, Zhu-Bin, Guan, Xiao-Qing, Yin, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154179/
https://www.ncbi.nlm.nih.gov/pubmed/35639783
http://dx.doi.org/10.1371/journal.pone.0267706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154179/
https://www.ncbi.nlm.nih.gov/pubmed/35639783
http://dx.doi.org/10.1371/journal.pone.0267706

Ejemplares similares